Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 7/20 | 0.80 |
| ▸ | APEX1 | P27695 | 3/20 | 0.80 |
| ▸ | APAF1 | O14727 | 2/20 | 0.80 |
| ▸ | LMNA | P02545 | 2/20 | 0.80 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.80 |
| ▸ | TSHR | P16473 | 1/20 | 0.80 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.80 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.80 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.80 |
| ▸ | MAPT | P10636 | 4/20 | 0.79 |
| ▸ | ABCC4 | O15439 | 3/20 | 0.79 |
| ▸ | CNR1 | P21554 | 1/20 | 0.79 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.79 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.79 |
| ▸ | MMP2 | P08253 | 1/20 | 0.79 |
| ▸ | NR1I2 | O75469 | 5/20 | 0.65 |
| ▸ | PPARG | P37231 | 2/20 | 0.65 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.65 |
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.65 |
| ▸ | SLC22A11 | Q9NSA0 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1405938 | 1.00 | TDP1 (0.80) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| SCHEMBL1405936 | 1.00 | TDP1 (0.80) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| SCHEMBL13071965 | 1.00 | TDP1 (0.80) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| SCHEMBL6079725 | 1.00 | TDP1 (0.80) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| SCHEMBL12809842 | 1.00 | TDP1 (0.80) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| SCHEMBL6079741 | 1.00 | TDP1 (0.80) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Hydrochloric Acid SCHEMBL5515645 | 0.99 | TDP1 (0.82) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Hydrochloric Acid SCHEMBL1405969 | 0.99 | TDP1 (0.82) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Hydrochloric Acid SCHEMBL3547739 | 0.99 | TDP1 (0.82) | TDP1APEX1APAF1LMNAL3MBTL1 | |
| Hydrochloric Acid SCHEMBL3547744 | 0.99 | TDP1 (0.82) | TDP1APEX1APAF1LMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1554289-B1 | A CEFDINIR INTERMEDIATE | SANDOZ AG (CH) | 2011-03-09 | — | — | EP | disclosed |
| US-7825241-B2 | Cefdinir intermediate | SANDOZ AG (CH) | 2010-11-02 | — | — | US | disclosed |
| US-20080081906-A1 | CEFDINIR INTERMEDIATE | KREMMINGER PETER | 2008-04-03 | — | — | US | disclosed |
| EP-1842852-A1 | A CEFDINIR INTERMEDIATE | Sandoz AG (CH) | 2007-10-10 | — | — | EP | disclosed |
| US-7250508-B2 | Cefdinir intermediate | SANDOZ AG (CH) | 2007-07-31 | — | — | US | disclosed |
| US-20060025586-A1 | Cefdinir intermediate | SANDOZ AG (CH) | 2006-02-02 | — | — | US | disclosed |
| EP-1554289-A1 | A CEFDINIR INTERMEDIATE | Sandoz AG (CH) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004016623-A1 | A CEFDINIR INTERMEDIATE | SANDOZ AG (CH) | 2004-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060025586-A1 | Cefdinir intermediate | PCMT1, SULT1E1, AASDHPPT | TDP1 4688/4885APEX1 4154/4885APAF1 4821/4885 |
| US-20080081906-A1 | CEFDINIR INTERMEDIATE | PCMT1, AASDHPPT, SULT1E1 | TDP1 4740/4885APEX1 4476/4885APAF1 4832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.